Bacteriophage Therapy TP-102 in Diabetic Foot Ulcers

Summary

This is a Phase I/IIa trial designed to evaluate topical bacteriophage therapy in patients with diabetic foot ulcers.

Timeline

Start

2021-03-22

Primary completion

2022-08-07

Completion

2022-09-05

Publications

• Nir-Paz R, Onallah H, Dekel M, Gellman YN, Haze A, Ben-Ami R, Braunstein R, Hazan R, Dror D, Oster Y, Cherniak M, Attal F, Barbosa AR, Dordio H, Wagner A, Jones-Dias D, Neves J, Barreto M, Leandro C, Corte-Real S, Garcia M. Randomized double-blind study on safety and tolerability of TP-102 phage cocktail in patients with infected and non-infected diabetic foot ulcers. Med. 2025 May 9;6(5):100565. doi: 10.1016/j.medj.2024.11.018. Epub 2024 Dec 30.

Drugs

Indications